Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining -0.64% today. In the last week its performance is 2.04%, and 13.44% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 82.04, so today’s gain of -0.64% is a significant step towards its target price. The GAP today is therefore -0.40%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 12155, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 97.10%.
At the current price of 84.46, it has a dividend yield of 1.88%, and its target price is 82.04. This is with a profit margin of 9.90%, and total debt/equity of 0.84. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 16.47, as well as a forward P/E of 15.67.
With a current EPS of 5.16, and a forecasted EPS growth for next year at 6.27%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.82%.
Performance for the year is 16.82%. Since its IPO date on 12/26/1996, the total performance to date is 21.42%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 355130, while its average volume is 1196.78. Whilst the total gain today was -0.64%, it did have a day high of -0.82%.
Volatility for this week has been at 1.47%, and 1.33% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 43.76%, while the 52-week-high has reached -0.82%.
Looking at its return of investments, which is 12.30%, and its return on assets is 7.50%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 19.00%. With a sales growth of 1.30% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.81, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 2.11, and the P/S is 1.62, along with a P/B of 2.62. Meanwhile it has a p/cash of 94.96.